Showing results (401-410 of 586) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid TumorsTimothy A Yap, Anthony W Tolcher, Ruth Plummer, et al.
Inorganic Chemistry|February 25, 2025
Mechanistic Investigations of a Hydrogen-Evolving Cobalt Diimine-Dioxime Complex in an Oxygen Environment: Roles of Secondary Coordination Sphere, Bro̷nsted Acid, and Axial LigandYu-Syuan Tsai, Yu-Wei Chen, Charasee Laddika Dayawansa, et al.
Cancer|March 29, 2016
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancerHelen Chow, Paramita M Ghosh, Ralph deVere White, et al.
Inorganic Chemistry|August 16, 2017
Electronic, Magnetic, and Redox Properties and O2 Reactivity of Iron(II) and Nickel(II) o-Semiquinonate Complexes of a Tris(thioether) Ligand: Uncovering the Intradiol Cleaving Reactivity of an Iron(II) o-Semiquinonate ComplexPeng Wang, Michelle M Killian, Mohamed R Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?Marta Capelan, Desamparados Roda, Elena Geuna, et al.
Genes & Cancer|July 7, 2016
Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapyRuth L Vinall, Clifford G Tepper, Alexandra A Z Ripoll, et al.
Angewandte Chemie (International Ed. in English)|August 30, 2014
Synthesis and isolation of an acyclic tridentate bis(pyridine)carbodicarbene and studies on its structural implications and reactivitiesYu-Chen Hsu, Jiun-Shian Shen, Bo-Chao Lin, et al.
Journal of Medicinal Chemistry|December 8, 2006
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonistsBertrand Le Bourdonnec, Allan J Goodman, Mathieu Michaut, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Temporally discordant chromatin accessibility and DNA demethylation define short and long-term enhancer regulation during cell fate specificationLindsey N Guerin, Timothy J Scott, Jacqueline A Yap, et al.
Cell Reports|May 11, 2025
Temporally discordant chromatin accessibility and DNA demethylation define short- and long-term enhancer regulation during cell fate specificationLindsey N Guerin, Timothy J Scott, Jacqueline A Yap, et al.
Pageof 59